What is ABT's current stock price?

As of now, ABT is trading at $108.61, with a daily change of -10.04%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABT Stock Analysis & IQ Rating | Abbott Laboratories

ABT ABT Badge

Abbott Laboratories

$108.61

-$12.12 | -10.04%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

Night.Owl Yesterday at 08:37

Plug Power saw notable momentum today as CEO Andy Marsh participated in an AMA on Reddit, sparking investor interest and driving the stock sharply higher. Traders were closely watching the session for signs of continued ...

ABT Stock IQ

Login to see Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABT Target Price

Login to display

Strengths

ABT Rewards

Upgraded on attractively valued

ABT Rewards

Trading below its fair value

ABT Rewards

Investors confidence is positive

ABT Price Performance

$124.4 (-12.69%)

$127.18 (-14.60%)

$131.37 (-17.33%)

$128.22 (-15.29%)

1year

6month

3month

1month

ABT Analysts Opinion

ABT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABT Analysts Opinion

ABT Analysts opinion is negative and it remained unchanged from the past 3 months

ABT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

89%

40%

67%

ABT Street Sentiment

ABT Street Sentiment is bullish and have positive views on the near-term outlook

ABT Risk Level

ABT has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABT Performance Sentiment

Sentiments overview associated with ABT events and the stock performance.

55%

40%

Positive

Negative

26 out of 47
events present

19 out of 47
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Linked to ABT

IQ

Close Price

Change

MRK

5.00

109.18

-1.74%

CVKD

2.53

7.64

+7.45%

PFE

4.93

26.10

+0.73%

AZN

4.07

91.69

+1.27%

OGN

4.40

9.74

+1.56%

Recently Viewed

Close Price

Change

ABT

Abbott Laboratories

108.61

-10.04%

ESI

Element Solutions

29.03

-0.80%

BULL

Webull Corp

7.83

+0.77%

BVFL

BV Financial Inc.

18.98

+2.32%

APPN

Appian Corporation C

29.33

+3.24%

ABT Latest Analysis +

Abbott Stock Slides 7% After Q4 Results And 2026 Outlook Disappoint Investors . (RTTNews) - Abbott Laboratories (ABT) shares fell 6.51% trading at $112.87 down $7.86 after the company reported its fourth quarter and full year 2025 results and issued its financial outlook for 2026.

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Abbott Laboratories Enters Oversold Territory. The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.

Thu Jan 22, 2026

$108.61 | -10.04%

Earnings

Technical

Abbott projects 7% organic sales growth and 10% EPS rise for 2026 as Nutrition pivots to volume recovery.

Thu Jan 22, 2026

$108.61 | -10.04%

Activity

Stock Market Today: Dow Gains 450 Points. Corning Rallies But Celestica Abbott Crushed (Live Coverage). The Dow Jones index rose Thursday on surprise GDP data. Nvidia and Tesla rallied in morning trading.The post Stock Market Today: Dow Gains 450 Points. Corning Rallies But Celestica Abbott Crushed (Live Coverage) appeared first on Investor'.s Business Daily.

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Noteworthy Thursday Option Activity: ABT ANET SMCI. Among the underlying components of the S&.P 500 index we saw noteworthy options trading volume today in Abbott Laboratories (Symbol: ABT) where a total of 44710 contracts have traded so far representing approximately 4.5 million underlying shares. That amounts to about 7

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Crude Oil Down 2%. Abbott Shares Fall Following Q4 Results. United States stocks traded higher midway through trading with the Nasdaq Composite gaining more than 200 points on Thursday.The Dow traded up 0.78% to 49462.35 while the NASDAQ gained 0.94% to 23443.19. The S&.P 500 also rose gaining 0.63% to 6918.78.Check This Out: Communication services shares gained by 1.3% on Thursday.In trading on Wednesday utilities stocks dipped by 0.5%.ABT) stock fell over 7% on Thursday after the company re

Thu Jan 22, 2026

$108.61 | -10.04%

Earnings

Momentum

Abbott Projects 2026 Organic Sales Growth In Range Of 6.5% To 7.5% . (RTTNews) - Abbott (ABT) issued full-year guidance for 2026. The company projects organic sales growth in the range of 6.5% to 7.5% and adjusted EPS of $5.55 to $5.80 which reflects 10% growth at the midpoint.

Thu Jan 22, 2026

$108.61 | -10.04%

Activity

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints. ABT) stock fell on Thursday after the company reported fourth-quarter 2025 sales and the first-quarter 2026 .The company reported quarterly sales of $11.46 billion slightly missing the .Sales increased 4.4% on a reported basis 3% on an organic basis or 3.8% when excluding COVID-19 testing-related sales.The United States MedTech giant reported adjusted earnings of $1.50 in line with Wall Street estimates.“.In 2025 we expanded margins

Thu Jan 22, 2026

$108.61 | -10.04%

Activity

Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms.

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Abbott Laboratories Non-GAAP EPS of $1.50 beats by $0.01 revenue of $11.46B misses by $340M.

Thu Jan 22, 2026

$108.61 | -10.04%

Earnings

FAQ About ABT Stock Insights

What is ABT current stock price?

What are ABT stock strengths?

What is ABT Risk Level?

What is ABT market cap and volume?

What is ABT current Stock IQ?

Should I buy ABT stock right now?

Is ABT a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABT?

What does a 'Strong Sell' rating mean for ABT?

What factors influence ABT's Stock IQ?

Explore our ABT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABT Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABT ABT Badge

Abbott Laboratories

Set Alerts

Current Price

$108.61

-$12.12 | -10.04%

52W High

$141.23

MKT CAP

$188.86B

52W Low

$105.78

VOL

$33.12M

P/E Ratio

13.56

AVG VOL

$6.52M

RSI

18.16

TREND

Downtrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Stock Insights

Strengths

ABT Rewards

Upgraded on attractively valued

ABT Rewards

Trading below its fair value

ABT Rewards

Investors confidence is positive

Linked to ABT

Symbol

IQ

Close

Change

MRK

5.00

109.18

-1.74%

CVKD

2.53

7.64

+7.45%

PFE

4.93

26.10

+0.73%

AZN

4.07

91.69

+1.27%

OGN

4.40

9.74

+1.56%

ABT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

89%

40%

67%

ABT Street Sentiment

ABT Street Sentiment is bullish and have positive views on the near-term outlook

ABT Risk Level

ABT has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABT Performance Sentiment

Sentiments overview associated with ABT events and the stock performance.

55%

40%

Positive

Negative

26 out of 47
events present

19 out of 47
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Latest Analysts Recommendations

Date

Action

Rating

Firm

Nov 20, 2025

Reiterate

Buy

BTIG

Oct 17, 2025

Reiterate

Overweight

Wells Fargo

Oct 17, 2025

Reiterate

Outperform

RBC

Oct 17, 2025

Reiterate

Outperform

Raymond James

Oct 17, 2025

Reiterate

Outperform

Evercore ISI

ABT Stock IQ

Login to unlock Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABT Latest Analysis

Night.Owl Yesterday at 08:37

Plug Power saw notable momentum today as CEO Andy Marsh participated in an AMA on Reddit, sparking investor interest and driving the stock sharply higher. Traders were closely watching the session for signs of continued ...

Abbott Stock Slides 7% After Q4 Results And 2026 Outlook Disappoint Investors . (RTTNews) - Abbott Laboratories (ABT) shares fell 6.51% trading at $112.87 down $7.86 after the company reported its fourth quarter and full year 2025 results and issued its financial outlook for 2026.

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Abbott Laboratories Enters Oversold Territory. The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.

Thu Jan 22, 2026

$108.61 | -10.04%

Earnings

Technical

Abbott projects 7% organic sales growth and 10% EPS rise for 2026 as Nutrition pivots to volume recovery.

Thu Jan 22, 2026

$108.61 | -10.04%

Activity

Stock Market Today: Dow Gains 450 Points. Corning Rallies But Celestica Abbott Crushed (Live Coverage). The Dow Jones index rose Thursday on surprise GDP data. Nvidia and Tesla rallied in morning trading.The post Stock Market Today: Dow Gains 450 Points. Corning Rallies But Celestica Abbott Crushed (Live Coverage) appeared first on Investor'.s Business Daily.

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Noteworthy Thursday Option Activity: ABT ANET SMCI. Among the underlying components of the S&.P 500 index we saw noteworthy options trading volume today in Abbott Laboratories (Symbol: ABT) where a total of 44710 contracts have traded so far representing approximately 4.5 million underlying shares. That amounts to about 7

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Crude Oil Down 2%. Abbott Shares Fall Following Q4 Results. United States stocks traded higher midway through trading with the Nasdaq Composite gaining more than 200 points on Thursday.The Dow traded up 0.78% to 49462.35 while the NASDAQ gained 0.94% to 23443.19. The S&.P 500 also rose gaining 0.63% to 6918.78.Check This Out: Communication services shares gained by 1.3% on Thursday.In trading on Wednesday utilities stocks dipped by 0.5%.ABT) stock fell over 7% on Thursday after the company re

Thu Jan 22, 2026

$108.61 | -10.04%

Earnings

Momentum

Abbott Projects 2026 Organic Sales Growth In Range Of 6.5% To 7.5% . (RTTNews) - Abbott (ABT) issued full-year guidance for 2026. The company projects organic sales growth in the range of 6.5% to 7.5% and adjusted EPS of $5.55 to $5.80 which reflects 10% growth at the midpoint.

Thu Jan 22, 2026

$108.61 | -10.04%

Activity

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints. ABT) stock fell on Thursday after the company reported fourth-quarter 2025 sales and the first-quarter 2026 .The company reported quarterly sales of $11.46 billion slightly missing the .Sales increased 4.4% on a reported basis 3% on an organic basis or 3.8% when excluding COVID-19 testing-related sales.The United States MedTech giant reported adjusted earnings of $1.50 in line with Wall Street estimates.“.In 2025 we expanded margins

Thu Jan 22, 2026

$108.61 | -10.04%

Activity

Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms.

Thu Jan 22, 2026

$108.61 | -10.04%

Momentum

Abbott Laboratories Non-GAAP EPS of $1.50 beats by $0.01 revenue of $11.46B misses by $340M.

Thu Jan 22, 2026

$108.61 | -10.04%

Earnings

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABT Stock trends

ABT Stock performance

ABT Stock analysis

ABT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

ABT Stock Analysis & IQ Rating | Abbott Laboratories

ABT Stock IQ

ABT Target Price

ABT Analysts Opinion

ABT Street Sentiment

ABT Risk Level

ABT Performance Sentiment

Explore our ABT Stock insights

Receive our ABT Daily Alerts

ABT Street Sentiment

ABT Risk Level

Latest Analysts Recommendations

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABT. We're here to help you make informed investment decisions today.

Receive our ABT Daily Alerts

ABT Alerts